Search research articles
Contact Us
Filters
Showing results (121-130 of 130) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 130 results.
Frontiers in Public Health
|
March 27, 2024
Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness
Alex Durand Nka, Yagai Bouba, Joseph Fokam, et al.
Frontiers in Immunology
|
August 30, 2023
Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies
Aude Christelle Ka'e, Aubin Joseph Nanfack, Georgia Ambada, et al.
BMC Infectious Diseases
|
May 5, 2025
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in Cameroon
Joseph Fokam, Aurelie Minelle Kengni Ngueko, Alex Durand Nka, et al.
Diagnostic Microbiology and Infectious Disease
|
February 5, 2026
Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countries
Joseph Fokam, Naomi-Karell Etame, Ezechiel Ngoufack Jagni Semengue, et al.
Medicine
|
June 19, 2023
Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics
Joseph Fokam, Alex Durand Nka, Flore Yollande Mamgue Dzukam, et al.
Medicine
|
May 19, 2025
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in Cameroon
Yagai Bouba, Aude Christelle Ka'e, Davy-Hyacinthe Anguechia Gouissi, et al.
PLOS Global Public Health
|
May 15, 2026
Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon: Implications for implementation in developing countries
Yagai Bouba, Aude Christelle Ka'e, Cynthia Ayafor, et al.
AIDS Research and Therapy
|
December 9, 2025
Low burden of clinically relevant anaemia and thrombocytopenia among adolescents living with HIV receiving tenofovir/lamivudine plus dolutegravir: the CIPHER-ADOLA study in Cameroon
Nadine Nguendjoung Fainguem, Yagai Bouba, Rachel Kamgaing, et al.
The Journal of Molecular Diagnostics : JMD
|
November 20, 2025
Updates on the Clinical Epidemiology of HIV-1 Group O Strains in Cameroon and Potential Implications on Diagnosis and Treatment Strategies
Joseph Fokam, Collins Ambe Chenwi, Désiré Augustin Takou Komego, et al.
Biomedicines
|
September 28, 2024
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study
Joseph Fokam, Yagai Bouba, Rogers Awoh Ajeh, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 130) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 130 results.
Frontiers in Public Health
|
March 27, 2024
Current knowledge of human Mpox viral infection among healthcare workers in Cameroon calls for capacity-strengthening for pandemic preparedness
Alex Durand Nka, Yagai Bouba, Joseph Fokam, et al.
Frontiers in Immunology
|
August 30, 2023
Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies
Aude Christelle Ka'e, Aubin Joseph Nanfack, Georgia Ambada, et al.
BMC Infectious Diseases
|
May 5, 2025
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in Cameroon
Joseph Fokam, Aurelie Minelle Kengni Ngueko, Alex Durand Nka, et al.
Diagnostic Microbiology and Infectious Disease
|
February 5, 2026
Evaluation of two bioinformatic algorithms for the interpretation of HIV-1 drug resistance and subtyping in Cameroon: Translational application for ART optimization in low-and middle-income countries
Joseph Fokam, Naomi-Karell Etame, Ezechiel Ngoufack Jagni Semengue, et al.
Medicine
|
June 19, 2023
Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics
Joseph Fokam, Alex Durand Nka, Flore Yollande Mamgue Dzukam, et al.
Medicine
|
May 19, 2025
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in Cameroon
Yagai Bouba, Aude Christelle Ka'e, Davy-Hyacinthe Anguechia Gouissi, et al.
PLOS Global Public Health
|
May 15, 2026
Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon: Implications for implementation in developing countries
Yagai Bouba, Aude Christelle Ka'e, Cynthia Ayafor, et al.
AIDS Research and Therapy
|
December 9, 2025
Low burden of clinically relevant anaemia and thrombocytopenia among adolescents living with HIV receiving tenofovir/lamivudine plus dolutegravir: the CIPHER-ADOLA study in Cameroon
Nadine Nguendjoung Fainguem, Yagai Bouba, Rachel Kamgaing, et al.
The Journal of Molecular Diagnostics : JMD
|
November 20, 2025
Updates on the Clinical Epidemiology of HIV-1 Group O Strains in Cameroon and Potential Implications on Diagnosis and Treatment Strategies
Joseph Fokam, Collins Ambe Chenwi, Désiré Augustin Takou Komego, et al.
Biomedicines
|
September 28, 2024
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study
Joseph Fokam, Yagai Bouba, Rogers Awoh Ajeh, et al.
Page
of 13